Literature DB >> 32390259

Stereoselective [4+2]-Cycloaddition with Chiral Alkenylboranes.

Dongshun Ni1, Brittany P Witherspoon2, Hong Zhang3,4, Chen Zhou1, K N Houk3, M Kevin Brown1.   

Abstract

A method for the stereoselective [4+2]-cycloaddition of alkenylboranes and dienes is presented. This transformation was accomplished through the introduction of a new strategy that involves the use of chiral N-protonated alkenyl oxazaborolidines as dieneophiles. The reaction leads to the formation of products that can be readily derivatized to more complex structural motifs through stereospecific transformations of the C-B bond such as oxidation and homologation. Detailed computation evaluation of the reaction has uncovered a surprising role of the counterion on stereoselectivity.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  alkenylboranes; chiral auxiliaries; cycloaddition; dienes; synthetic methods

Year:  2020        PMID: 32390259     DOI: 10.1002/anie.202000652

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  3 in total

1.  Stereocontrolled Pericyclic and Radical Cycloaddition Reactions of Readily Accessible Chiral Alkenyl Diazaborolidines.

Authors:  Mingkai Zhang; Peilin Xu; Alex J Vendola; Christophe Allais; Anne-Marie Dechert Schmitt; Robert A Singer; James P Morken
Journal:  Angew Chem Int Ed Engl       Date:  2022-06-08       Impact factor: 16.823

2.  Photosensitized [2+2]-Cycloadditions of Alkenylboronates and Alkenes.

Authors:  Yanyao Liu; Dongshun Ni; Bernard G Stevenson; Vikrant Tripathy; Sarah E Braley; Krishnan Raghavachari; John R Swierk; M Kevin Brown
Journal:  Angew Chem Int Ed Engl       Date:  2022-04-21       Impact factor: 16.823

3.  Z-Selective Dienylation Enables Stereodivergent Construction of Dienes and Unravels a Ligand-Driven Mechanistic Dichotomy.

Authors:  Hang T Dang; Viet D Nguyen; Graham C Haug; Ngan T H Vuong; Hadi D Arman; Oleg V Larionov
Journal:  ACS Catal       Date:  2021-01-07       Impact factor: 13.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.